The 2nd NOAR Europe Annual Meeting is now SOLD OUT. Thank you all for your outstanding interest and support!
Organised by Jean-François Gestin in collaboration with Bernd Neumaier, the meeting will take place from 2 to 4 December 2026 at ONEPOINT Nantes (3 rue Lavoisier, 44100 Nantes, France).
This edition goes back to what made the meeting a success: a dedicated astatine-211 event, leaving some room for the other alphas. NOAR Europe brings together an international and interdisciplinary community dedicated to advancing astatine-211 based radiopharmaceuticals and targeted alpha therapy.
Programme at a glance
- Wednesday 2 December: the Alpha session, addressing common Alpha issues
- Thursday 3 and Friday 4 December: the NOAR Astatine track, from production and radiochemistry of astatine-211 to biological evaluation, dosimetry and clinical perspectives
- Social programme: cocktail sponsored by IBA on 2 December and gala dinner sponsored by Framatome on 3 December
- Visits: on Friday 4 December afternoon, visit of the Arronax cyclotron or the CRCINA laboratory (limited number of participants, on registration only, please contact noar2026@groupeonepoint.com before 17 November 2026)
Video challenge: take your phone and make your own video! Deadline: Friday 13 November. The top three videos (3 to 5 minutes) will be showcased during the plenary session, with a prize awarded to the winning submission.
You can find the full preliminary programme, sponsors, venue plans and accommodation 👉 HERE
For any further information, please contact the NOAR 2026 team: noar2026@groupeonepoint.com
